Records containing: Pancreatic Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-09-25Evaluating Obesity-Mediated Mechanisms of Pancreatic Carcinogenesis in Minority Populations
-
CLINICAL_TRIALS study record update · 2026-09-25A Phase 1b/2 Trial of Onvansertib in Combination With NALIRIFOX for First Line Treatment of Advanced Pancreatic Cancer
-
CLINICAL_TRIALS study record update · 2026-09-25Effectiveness of T-DXd Across HER2-positive Solid Tumors in Patients Who Have Received Prior Systemic Treatment and Have no Satisfactory Alternative Treatment Options: A Hybrid Observational Study
-
CLINICAL_TRIALS study record update · 2026-09-25Phase I/II Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells Delivered Intraperitoneally for the Management of Platinum Resistant Ovarian Cancer, Mesonephric-like Adenocarcinoma, and Pancreatic Cancer
-
CLINICAL_TRIALS study record update · 2026-09-24EXCEED - A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-09-23Cancer Coaching and Remote Education for Self-Empowerment (CARES) Study
-
CLINICAL_TRIALS study record update · 2026-09-23Radiology Registry on Pancreatic Malignancies
-
CLINICAL_TRIALS study record update · 2026-09-23Metastatic Non-Familial Adenocarcinoma Maintenance Therapy With DZ-002: Heptamine Carboxymethine Dye Conjugate
-
CLINICAL_TRIALS study record update · 2026-09-23Using Radiogenomics to Noninvasively Predict the Malignant Potential of Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas and Uncover Hidden Biology
-
CLINICAL_TRIALS study record update · 2026-09-22A Phase 3, Double-blind, Placebo-controlled, Randomized Study to Assess the Efficacy and Safety of ASP3082 in Combination With mFOLFIRINOX or NALIRIFOX as First-line Treatment in Participants With KRAS G12D Mutated Metastatic Pancreatic Adenocarcinoma
-
CLINICAL_TRIALS study record update · 2026-09-22Population-Based Analysis of Neoplastic Changes in Cystic Lesions of the Pancreas.
-
CLINICAL_TRIALS study record update · 2026-09-22A Prospective Pilot Clinical Trial of Simulation-Free Celiac Plexus Pain Ablation Using Stereotactic Body Radiotherapy in Patients With Cancer-Related Celiac Pain
-
CLINICAL_TRIALS study record update · 2026-09-21SURG-236: Prehabilitation in High-risk Oncologic Surgery: A Prospective Cohort Study
-
CLINICAL_TRIALS study record update · 2026-09-21A Modular Phase I/IIa, Open-label, Multicentre Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of Ascending Doses of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies
-
CLINICAL_TRIALS study record update · 2026-09-21A Phase 2 Study With Combination Chemotherapy (Gemcitabine and Nab-Paclitaxel), Chemokine (C-X-C) Motif Receptor 4 Inhibitor (BL-8040), and Immune Checkpoint Blockade (Cemiplimab) in METastatic Treatment naïve PANCreas Adenocarcinoma
-
CLINICAL_TRIALS study record update · 2026-09-18Predicting Pancreatic Fistula After Pancreatic Surgery Using Preoperative Immunity
-
CLINICAL_TRIALS study record update · 2026-09-18PHASE 1, OPEN-LABEL, FIRST-IN-HUMAN TRIAL OF INTRAPERITONEA L Lm-LLO-TT AND GEMCITABINE IN PARTICIPANTS WITH UNRESECTABLE PANCREATIC DUCTAL ADENOCARCINOMA
-
CLINICAL_TRIALS study record update · 2026-09-18A Multi-cohort Exploratory Study to Evaluate the Efficacy and Safety of Albumin-bound Paclitaxel (Ⅱ)-Combined Regimens for Pancreatic Cancer
-
CLINICAL_TRIALS study record update · 2026-09-18A Safety Study of Intraoperative Radiation Therapy Following Stereotactic Body Radiation Therapy and Multi-agent Chemotherapy in the Treatment of Localized Pancreatic Adenocarcinoma
-
CLINICAL_TRIALS study record update · 2026-09-18GLP-1 Receptor Agonist Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer
-
CLINICAL_TRIALS study record update · 2026-09-17Phase 1/1b, Multicenter, Open-Label, Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-09-17A ProSPEctivE Study of NGDS DMAT Workflow Feasibility
-
CLINICAL_TRIALS study record update · 2026-09-17Clinical Outcomes and Safety of Fluoroscopy-Guided Transdiscal Splanchnic Nerve Neurolysis in Patients With Upper Abdominal Cancer Pain: A Prospective Cohort Study
-
CLINICAL_TRIALS study record update · 2026-09-17Neoadjuvant Avutometinib/Defactinib and mFOLFIRINOX Combination Therapy in Pancreatic Adenocarcinoma: A Phase IB/II Safety and Efficacy Study
-
CLINICAL_TRIALS study record update · 2026-09-17An Open-label, Multicenter, Dose Escalation and Expansion Phase 1/2 Study to Evaluate the Safety, Tolerability and Pharmacokinetics, and Anti-tumor Activity of GI-108, an Anti-CD73-IgG4 Fc-IL-2v Bispecific Fusion Protein, as a Single Agent in Patients With Advanced or Metastatic Solid Tumors